Done. The Reduction of both Cyclophilin B and HCV-RNA by the Cyclophilin Inhibitor Debio-025 Confirms the Importance of Cyclophilin B for HCV replication in Man - Debiopharm
Home Drug development Publications The Reduction of both Cyclophi…

The Reduction of both Cyclophilin B and HCV-RNA by the Cyclophilin Inhibitor Debio-025 Confirms the Importance of Cyclophilin B for HCV replication in Man

P. Gallay, R. Flisiak, A. Horban, C. Aeschlimann, J.M. Dumont, H. Porchet, P. Scalfaro, R. Crabbé

42nd Anual Meeting of the European Association for the Study of the Liver – Barcelona/Spain